Author:
Dresemann Gregor,Weller Michael,Rosenthal Mark A.,Wedding Ulrich,Wagner Wolfgang,Engel Erik,Heinrich Bernhard,Mayer-Steinacker Regine,Karup-Hansen Anders,Fluge Øystein,Nowak Anna,Mehdorn Maximilian,Schleyer Eberhard,Krex Dietmar,Olver Ian N.,Steinbach Joachim P.,Hosius Christian,Sieder Christian,Sorenson Greg,Parker Richard,Nikolova Zariana
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Clinical Neurology,Neurology,Oncology
Reference17 articles.
1. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996. doi: 10.1056/NEJMoa043330
2. Sathornsumetee S, Reardon DA, Desjardins A et al (2007) Molecularly targeted therapy for malignant glioma. Cancer 110:13–24. doi: 10.1002/cncr.22741
3. Joensuu H, Puputti M, Sihto H et al (2005) Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme. J Pathol 207:224–231. doi: 10.1002/path.1823
4. Buie LW, Valgus JM (2008) Bevacizumab: a treatment option for recurrent glioblastoma multiforme. Ann Pharmacother 42:1486–1490. doi: 10.1345/aph.1L030
5. Raymond E, Brandes A, Van Oosterom A et al (2004) Multicentre phase II study of imatinib mesylate in patients with recurrent glioblastoma: an EORTC:NDDG/BTG intergroup study. Proc Am Soc Clin Oncol 23:107 abstract
Cited by
128 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献